BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Khanna S, Gerding DN. Current and future trends in clostridioides (clostridium) difficile infection management. Anaerobe 2019;58:95-102. [PMID: 31054313 DOI: 10.1016/j.anaerobe.2019.04.010] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 4.7] [Reference Citation Analysis]
Number Citing Articles
1 Kociolek LK, Crews JD, Schwenk HT. Recent advances in Clostridioides difficile infection epidemiology, diagnosis and treatment in children. Curr Opin Infect Dis 2021. [PMID: 34232137 DOI: 10.1097/QCO.0000000000000753] [Reference Citation Analysis]
2 Youngster I. Another step in the journey - from feces to regulated microbial therapeutics. Clin Infect Dis 2020:ciaa1435. [PMID: 32961549 DOI: 10.1093/cid/ciaa1435] [Reference Citation Analysis]
3 Stewart D, Anwar F, Vedantam G. Anti-virulence strategies for Clostridioides difficile infection: advances and roadblocks. Gut Microbes 2020;12:1802865. [PMID: 33092487 DOI: 10.1080/19490976.2020.1802865] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
4 Petrosillo N, Cataldo MA. Clostridioides difficile Infection: A Room for Multifaceted Interventions. J Clin Med 2020;9:E4114. [PMID: 33419243 DOI: 10.3390/jcm9124114] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
5 Cox LM, Seekatz AM, Fichorova RN. Introduction to the special issue for The anaerobe society of the America's 14th Biennial congress in Las Vegas. Anaerobe 2019;58:1-5. [PMID: 31255715 DOI: 10.1016/j.anaerobe.2019.06.011] [Reference Citation Analysis]
6 Ernst K, Landenberger M, Nieland J, Nørgaard K, Frick M, Fois G, Benz R, Barth H. Characterization and Pharmacological Inhibition of the Pore-Forming Clostridioides difficile CDTb Toxin. Toxins (Basel) 2021;13:390. [PMID: 34071730 DOI: 10.3390/toxins13060390] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Dudzicz S, Wiecek A, Adamczak M. Clostridioides difficile Infection in Chronic Kidney Disease-An Overview for Clinicians. J Clin Med 2021;10:E196. [PMID: 33430465 DOI: 10.3390/jcm10020196] [Reference Citation Analysis]
8 Fuchs M, Lamm-Schmidt V, Sulzer J, Ponath F, Jenniches L, Kirk JA, Fagan RP, Barquist L, Vogel J, Faber F. An RNA-centric global view of Clostridioides difficile reveals broad activity of Hfq in a clinically important gram-positive bacterium. Proc Natl Acad Sci U S A 2021;118:e2103579118. [PMID: 34131082 DOI: 10.1073/pnas.2103579118] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
9 Hughes J, Aston C, Kelly ML, Griffin R. Towards Development of a Non-Toxigenic Clostridioides difficile Oral Spore Vaccine against Toxigenic C. difficile. Pharmaceutics 2022;14:1086. [DOI: 10.3390/pharmaceutics14051086] [Reference Citation Analysis]
10 Abad CLR, Safdar N. A Review of Clostridioides difficile Infection and Antibiotic-Associated Diarrhea. Gastroenterol Clin North Am 2021;50:323-40. [PMID: 34024444 DOI: 10.1016/j.gtc.2021.02.010] [Reference Citation Analysis]
11 Pokhrel A, Poudel A, Castro KB, Celestine MJ, Oludiran A, Rinehold AJ, Resek AM, Mhanna MA, Purcell EB. The (p)ppGpp Synthetase RSH Mediates Stationary-Phase Onset and Antibiotic Stress Survival in Clostridioides difficile. J Bacteriol 2020;202:e00377-20. [PMID: 32661079 DOI: 10.1128/JB.00377-20] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
12 Cao X, Tang L, Zeng Z, Wang B, Zhou Y, Wang Q, Zou P, Li W. Effects of Probiotics BaSC06 on Intestinal Digestion and Absorption, Antioxidant Capacity, Microbiota Composition, and Macrophage Polarization in Pigs for Fattening. Front Vet Sci 2020;7:570593. [PMID: 33240950 DOI: 10.3389/fvets.2020.570593] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
13 Oksi J, Anttila VJ, Mattila E. Treatment of Clostridioides (Clostridium) difficile infection. Ann Med 2020;52:12-20. [PMID: 31801387 DOI: 10.1080/07853890.2019.1701703] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
14 Wong D, Nanda N. Clostridium difficile disease in solid organ transplant recipients: a recommended treatment paradigm. Curr Opin Organ Transplant 2020;25:357-63. [PMID: 32618715 DOI: 10.1097/MOT.0000000000000778] [Reference Citation Analysis]